Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

STEM-CORE Stem Cell Therapy Development for Corneal Epithelium Regeneration

Coordinator
Stichting Radboud Universiteit, Netherlands
Runs
1 January 2026 to 31 December 2029
Status
Running
EU funding
€4.1m
Total cost
—
Partners
18 organisations in 10 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226474

What the project is doing

In the project's own words, from its summary on CORDIS.

Corneal disease ranks as the fourth major cause of blindness, imposing a significant medical, social, and economic burden. Effective therapeutic options for corneal disease are unfortunately limited. The development of regenerative treatment has proven more complex than anticipated. Bridging the gap between cutting-edge scientific and technological advancements and their clinical applications in ocular regenerative medicine requires equipping the next generation of (medical) researchers with comprehensive training to drive innovation and facilitate clinical translation.

STEM-CORE aims to reshape European doctorate education, through ‘training through innovative research’, nurturing future leaders in ocular regenerative medicine and beyond. This training program offers doctoral candidates (DCs) a comprehensive training trajectory to develop a robust, affordable, and sustainable cell therapy for treating corneal blindness caused by stem cell deficiency. Key components include in-depth understanding of stem cell differentiation, developing (genetically corrected) cell products and biomaterials, and evaluating regenerative function of the cell products in corneas.

Through innovative, interdisciplinary and intersectoral research, STEM-CORE provides training of a full set of transferable and other complementary skills to DCs that enhances their career prospects across academia and industry. To achieve this, STEM-CORE has assembled a team of leading European researchers and dedicated supervisors from academic and non-academic sectors, whose expertise spans all facets of the training program.

We envision that STEM-CORE will not only establish a novel paradigm for cell therapy development but also empower aspiring researchers to tackle broad challenges in future regenerative medicine, advancing European innovation and contributing to societal progress.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Radboud UniversiteitNijmegenNetherlandsCoordinator
Klinikum Der Universitaet Zu KoelnKoelnGermanyParticipant
Universitat Des SaarlandesSaarbruckenGermanyParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Universitat Autonoma De BarcelonaCerdanyola Del VallesSpainAssociatedpartner
Tampereen Korkeakoulusaatio SrTampereFinlandParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
Universite Paris-SaclayGif-Sur-YvetteFranceAssociatedpartner
Biotalentum Tudasfejleszto KftGoedoelloHungaryParticipant
Eotvos Lorand TudomanyegyetemBudapestHungaryAssociatedpartner
Fondazione Banca Degli Occhi Del Veneto OnlusZelarino VeneziaItalyParticipant
SBMatrices B.V.MaldenNetherlandsAssociatedpartner
Stichting Oogfonds NederlandUtrechtNetherlandsAssociatedpartner
Universiteit UtrechtUtrechtNetherlandsAssociatedpartner
Aniridia EuropeSandefjordNorwayAssociatedpartner
Linkopings UniversitetLinkopingSwedenParticipant
Dokuz Eylul UniversitesiAlsancak IzmirTürkiyeAssociatedpartner
Izmir Biyotip Ve Genom MerkeziİzmirTürkiyeParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI